The conversation delves into the complexities of autoimmune responses, particularly how antibodies target beta cells in the pancreas in type 1 diabetes. Despite the destruction, some beta cells may remain functional, as indicated by c-peptide levels in long-term diabetics. This ongoing insulin secretion is often overshadowed by the autoimmune system's relentless attack, highlighting the intricate balance within the body's response to diabetes.
